Combining Pentoxifylline With Vedolizumab for Crohn's Disease: Results of a Randomised, Placebo-controlled Pilot Study.

Shivali Berera,Stephanie C Ioannou,Diana Morillo,Alejandro M A Mantero,Judith Pignac-Kobinger, Niurka Colina,Ana M Santander,Irina Fernandez,Maria Alejandra Quintero, Jennifer Rodriguez,David H Kerman,Oriana M Damas,Frank Czul,Daniel A Sussman,Maria T Abreu,Amar R Deshpande

Journal of Crohn's & colitis（2022）

引用 1|浏览8

暂无评分

摘要

VDZ/PTX did not provide benefit over VDZ monotherapy in clinical or endoscopic remission but appeared to improve clinical response and was safe. These data should inform a fully powered study.

查看译文

关键词

Crohn’s disease,Vedolizumab,pentoxifylline

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要